Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Pochinco

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the American Society of Nephrology : JASN|December 31, 2002
Heightened peripheral blood lymphocyte CD69 expression is neither sensitive nor specific as a noninvasive diagnostic test for renal allograft rejectionMartin Karpinski, David Rush, John Jeffery, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidatesMartin Karpinski, Denise Pochinco, Iga Dembinski, et al.
Transplant Immunology|December 9, 2017
Pre-transplant AT<sub>1</sub>R antibodies correlate with early allograft rejectionAlison J Gareau, Chris Wiebe, Denise Pochinco, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatchMartin Karpinski, David Rush, John Jeffery, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2018
HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunityChris Wiebe, Vasilis Kosmoliaptsis, Denise Pochinco, et al.
Canadian Journal of Kidney Health and Disease|October 15, 2024
Program Report: Expanding the Deceased Donor Pool in Manitoba With an Age-Targeted Kidney Transplant ProgramAaron Trachtenberg, Vaishali Shenoy, Nancy Dodd, et al.
Frontiers in Genetics|September 12, 2024
HLA-DR/DQ eplet mismatch predicts <i>de novo</i> donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimensEmmett Tsz Yeung Wong, Denise Pochinco, Anantharaman Vathsala, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2020
Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejectionChris Wiebe, David N Rush, Ian W Gibson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2023
A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppressionChris Wiebe, Rob Balshaw, Ian W Gibson, et al.
Human Immunology|July 27, 2025
Corrigendum to "HLA-DQ heterodimer mismatch as a predictor of post-transplant alloimmunity and allograft survival". [Hum. Immunol. 86 (2025) 111345]Emmett Tsz Yeung Wong, Robert Balshaw, Ian W Gibson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the American Society of Nephrology : JASN|December 31, 2002
Heightened peripheral blood lymphocyte CD69 expression is neither sensitive nor specific as a noninvasive diagnostic test for renal allograft rejectionMartin Karpinski, David Rush, John Jeffery, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidatesMartin Karpinski, Denise Pochinco, Iga Dembinski, et al.
Transplant Immunology|December 9, 2017
Pre-transplant AT<sub>1</sub>R antibodies correlate with early allograft rejectionAlison J Gareau, Chris Wiebe, Denise Pochinco, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatchMartin Karpinski, David Rush, John Jeffery, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2018
HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunityChris Wiebe, Vasilis Kosmoliaptsis, Denise Pochinco, et al.
Canadian Journal of Kidney Health and Disease|October 15, 2024
Program Report: Expanding the Deceased Donor Pool in Manitoba With an Age-Targeted Kidney Transplant ProgramAaron Trachtenberg, Vaishali Shenoy, Nancy Dodd, et al.
Frontiers in Genetics|September 12, 2024
HLA-DR/DQ eplet mismatch predicts <i>de novo</i> donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimensEmmett Tsz Yeung Wong, Denise Pochinco, Anantharaman Vathsala, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2020
Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejectionChris Wiebe, David N Rush, Ian W Gibson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2023
A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppressionChris Wiebe, Rob Balshaw, Ian W Gibson, et al.
Human Immunology|July 27, 2025
Corrigendum to "HLA-DQ heterodimer mismatch as a predictor of post-transplant alloimmunity and allograft survival". [Hum. Immunol. 86 (2025) 111345]Emmett Tsz Yeung Wong, Robert Balshaw, Ian W Gibson, et al.
Pageof 2